Loading...
Please wait, while we are loading the content...
Similar Documents
Circulating tumor cells as a potential biomarker for postoperative clinical outcome in HBV-related hepatocellular carcinoma
| Content Provider | Scilit |
|---|---|
| Author | Ye, Xinping Li, Guanghui Han, Chuangye Han, Quanfa Shang, Liming Su, Hao Han, Bowen Gong, Yizhen Lu, Guodong Peng, Tao |
| Copyright Year | 2018 |
| Description | Journal: Cancer Management and Research |
| Abstract | Circulating tumor cells as a potential biomarker for postoperative clinical outcome in HBV-related hepatocellular carcinoma Xinping Ye,1,* Guanghui Li,1,* Chuangye Han,1 Quanfa Han,1 Liming Shang,1 Hao Su,1 Bowen Han,1 Yizhen Gong,1 Guodong Lu,2 Tao Peng1 1Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China; 2Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning, Guangxi Province, China *These authors contributed equally to this work Background: This study aimed to determine if the number of circulating tumor cells (CTCs) and changes in their numbers affected tumor recurrence and metastasis after surgical resection in patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Methods: The primary endpoints were overall survival (OS) and progression-free survival (PFS). A total of 42 patients with HCC were selected from the First Affiliated Hospital of Guangxi Medical College from 2014 to 2017. CTCs were counted 1 day prior to and 30 days after surgical excision of HCC using the CanPatrol™ system. Results: Numbers of CTCs (> 2 CTCs and > 5 CTCs per 5 ml peripheral blood) were significantly associated with Edmondson stage in HBV-related HCC prior to surgery (P = 0.004 and 0.014, respectively). However there were no significant associations between other tested clinicopathological factors and CTC counts. Postoperative CTC counts (> 2 and > 5) and pre/postoperative change in CTC counts were significantly associated with PFS (P = 0.02, 0.009, and 0.001, respectively), but not with OS. Receiver operating characteristic curve analysis showed that pre/postoperative changes in the CTC count were a better predictor of performance than absolute count. The postoperative CTC count was also significantly associated with positive TP53 expression (P < 0.05). Conclusion: These results demonstrate that postoperative CTC counts (> 2 and > 5) and changes in CTC counts may be independent prognostic indicators for PFS in patients with HBV-related HCC, with the change in number of CTCs showing better predictive performance. Keywords: circulating tumor cell, hepatocellular carcinoma, progression-free survival, overall survival |
| Related Links | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245351/pdf https://www.dovepress.com/getfile.php?fileID=46204 |
| Ending Page | 5647 |
| Page Count | 9 |
| Starting Page | 5639 |
| ISSN | 11791322 |
| DOI | 10.2147/cmar.s175489 |
| Journal | Cancer Management and Research |
| Volume Number | ume 10 |
| Language | English |
| Publisher | Informa UK Limited |
| Publisher Date | 2018-11-01 |
| Access Restriction | Open |
| Subject Keyword | Journal: Cancer Management and Research Gastroenterology and Hepatology Circulating Tumor Cell Hepatocellular Carcinoma Progression-free Survival Overall Survival |
| Content Type | Text |
| Subject | Oncology |
